AMGN · NASDAQ
Amgen (AMGN) Stock Price & Fundamentals
Amgen (AMGN) closed at $1,237.62 on Oct 9, 2026, down 0.87% from the previous close of $1,248.52.
Share price, past year
1Y +23.50%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,237.62 |
| Sep 30, 2026 | $1,236.18 |
| Aug 31, 2026 | $1,161.90 |
| Jul 31, 2026 | $1,149.30 |
| Jun 30, 2026 | $1,120.57 |
| May 29, 2026 | $1,117.14 |
| Apr 30, 2026 | $1,039.27 |
| Mar 31, 2026 | $1,044.85 |
| Feb 27, 2026 | $1,047.90 |
| Jan 30, 2026 | $1,062.99 |
| Dec 31, 2025 | $1,025.64 |
| Nov 28, 2025 | $958.18 |
| Oct 31, 2025 | $975.71 |
Key statistics
- Market cap
- $669.06B
- P/E (TTM)
- 76.9
- EPS (TTM)
- $16.09
- Revenue (TTM)
- $38.10B
- Net income (TTM)
- $8.74B
- Shares outstanding
- 540.6M
- Dividend yield
- 0.79%
- 52-week range
- $925.56 – $1,260.79
Amgen's market cap is $669.06B, based on a share price of $1,237.62 and 540.6M shares outstanding as of Jun 30, 2026.
Financials
Amgen reported revenue of $36.75B for fiscal 2025, up 9.95% from fiscal 2024.
Amgen earned net income of $7.71B in fiscal 2025, a net margin of 21.0%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $36.75B | +10.0% | $7.71B | 21.0% | $14.23 | $8.10B |
| FY2024ended Dec 31, 2024 | $33.42B | +18.6% | $4.09B | 12.2% | $7.56 | $10.39B |
| FY2023ended Dec 31, 2023 | $28.19B | +7.1% | $6.72B | 23.8% | $12.49 | $7.36B |
| FY2022ended Dec 31, 2022 | $26.32B | +1.3% | $6.55B | 24.9% | $12.11 | $8.79B |
| FY2021ended Dec 31, 2021 | $25.98B | +2.2% | $5.89B | 22.7% | $10.28 | $8.38B |
| FY2020ended Dec 31, 2020 | $25.42B | +8.8% | $7.26B | 28.6% | $12.31 | $9.89B |
| FY2019ended Dec 31, 2019 | $23.36B | −1.6% | $7.84B | 33.6% | $12.88 | $8.53B |
| FY2018ended Dec 31, 2018 | $23.75B | +3.9% | $8.39B | 35.4% | $12.62 | $10.56B |
| FY2017ended Dec 31, 2017 | $22.85B | −0.6% | $1.98B | 8.7% | $2.69 | $10.51B |
| FY2016ended Dec 31, 2016 | $22.99B | — | $7.72B | 33.6% | $10.24 | $9.62B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $10.05B | $2.38B | $4.37 |
| Q1 FY2026ended Mar 31, 2026 | $8.62B | $1.82B | $3.34 |
| Q4 FY2025ended Dec 31, 2025 | $9.87B | $1.33B | $2.45 |
| Q3 FY2025ended Sep 30, 2025 | $9.56B | $3.22B | $5.93 |
| Q2 FY2025ended Jun 30, 2025 | $9.18B | $1.43B | $2.65 |
| Q1 FY2025ended Mar 31, 2025 | $8.15B | $1.73B | $3.20 |
| Q4 FY2024ended Dec 31, 2024 | $9.09B | $627.00M | $1.17 |
| Q3 FY2024ended Sep 30, 2024 | $8.50B | $2.83B | $5.22 |
Company profile
- Name
- Amgen Inc.
- Ticker
- AMGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- One Amgen Center Drive, Thousand Oaks, CA 91320
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000318154
Recent SEC filings
- Aug 5, 2026
- Aug 4, 2026
- Jul 31, 2026
- May 20, 2026
- May 19, 2026
- May 1, 2026
- Apr 30, 2026
- Apr 22, 2026
Frequently asked questions
What is Amgen's stock price?
Amgen (AMGN) closed at $1,237.62 on Oct 9, 2026, down 0.87% from the previous close of $1,248.52.
What is Amgen's market cap?
Amgen's market cap is $669.06B, based on a share price of $1,237.62 and 540.6M shares outstanding as of Jun 30, 2026.
How much revenue does Amgen make?
Amgen reported revenue of $36.75B for fiscal 2025, up 9.95% from fiscal 2024.
What is AMGN's P/E ratio?
Amgen's price-to-earnings ratio is 76.9, based on trailing twelve-month diluted EPS of $16.09.
Does Amgen pay a dividend?
Yes. Amgen declared $9.80 per share in dividends over the last four quarters, a yield of 0.79%.
Sources and methodology
Fundamentals come from Amgen Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures